IncellDx Advancing Toward Filing for FDA Clearance of HPV Test

The company, which recently raised $3 million in Series A financing, plans to file for FDA clearance for its HPV test and a test for HIV tropism.

Full-text access for registered users only. Existing users login here.
New to GenomeWeb? Register here quickly for free access.

Related Stories